FDA Grants Breakthrough Designation for Multiple Myeloma Drug

News   May 20, 2014

 
FDA Grants Breakthrough Designation for Multiple Myeloma Drug
 
 
 

RELATED ARTICLES

Boyds Acquires New Cambridge Office to Support Rapid Growth

News

Boyds, the drug development consultancy which helps pharmaceutical companies translate great science into marketable medicines for patient benefit, has relocated into new premises in Cambridge.

READ MORE

Protein That Helps Keep Breast Cancer Dormant Identified

News

A protein kinase that stops breast cancer cells growing and spreading has been outlined in new research.

READ MORE

Vaccines Are Not Protecting Farmed Fish From Disease

News

The vaccines used by commercial fish farmers are not protecting fish from disease, according to a new study. It showed vaccinated fish tend to show more symptoms when contracting diseases, with the health impacts and ultimately deaths occurring as if they’d never received a vaccine.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Cancer Research Cell Science Drug Discovery Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE